Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Maximal Bruce Protocol With the Use of Regadenoson For Myocardial Perfusion Stress Testing

NCT01026012 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.

NCT NCT01026012
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01026012 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Maximal Bruce Protocol With the Use of Regadenoson For Myocardial Perfusion Stress Testing
Lead sponsor
University of Maryland, Baltimore
Phase
Not applicable
Overall status
Completed
Start date
December 31, 2009
Completion date
September 30, 2010
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac function